Pasquale Caponnetto

ORCID: 0000-0001-7414-155X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Smoking Behavior and Cessation
  • Asthma and respiratory diseases
  • Obesity, Physical Activity, Diet
  • Air Quality and Health Impacts
  • Behavioral Health and Interventions
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Digital Mental Health Interventions
  • Respiratory and Cough-Related Research
  • Impact of Technology on Adolescents
  • Sexuality, Behavior, and Technology
  • Schizophrenia research and treatment
  • COVID-19 and Mental Health
  • Mobile Health and mHealth Applications
  • Nicotinic Acetylcholine Receptors Study
  • Olfactory and Sensory Function Studies
  • Healthcare professionals’ stress and burnout
  • Pediatric health and respiratory diseases
  • Educational and Social Studies
  • Psychosomatic Disorders and Their Treatments
  • Consumer Attitudes and Food Labeling
  • Mental Health Research Topics
  • Health, psychology, and well-being
  • Body Image and Dysmorphia Studies
  • Noise Effects and Management
  • Cardiac Health and Mental Health

University of Catania
2015-2025

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2023

Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele
2011-2023

University of West Attica
2023

Villa Melitta
2019-2022

University of Stirling
2018-2021

Policlinico Universitario di Catania
2012-2020

Hospital de Santa Marta
2011

Electronic cigarettes (e-cigarettes) are becoming increasingly popular with smokers worldwide. Users report buying them to help quit smoking, reduce cigarette consumption, relieve tobacco withdrawal symptoms, and continue having a 'smoking' experience, but reduced health risks. Research on e-cigarettes is urgently needed in order ensure that the decisions of regulators, healthcare providers consumers based science. Methods ECLAT prospective 12-month randomized, controlled trial evaluates...

10.1371/journal.pone.0066317 article EN cc-by PLoS ONE 2013-06-24

Cigarette smoking is a tough addiction to break. Therefore, improved approaches cessation are necessary. The electronic-cigarette (e-Cigarette), battery-powered electronic nicotine delivery device (ENDD) resembling cigarette, may help smokers remain abstinent during their quit attempt or reduce cigarette consumption. Efficacy and safety of these devices in long-term and/or reduction studies have never been investigated.In this prospective proof-of-concept study we monitored possible...

10.1186/1471-2458-11-786 article EN cc-by BMC Public Health 2011-10-11

Although electronic cigarettes (ECs) are a much less harmful alternative to tobacco cigarettes, there is concern as whether long-term ECs use may cause risks human health. We report health outcomes (blood pressure, heart rate, body weight, lung function, respiratory symptoms, exhaled breath nitric oxide [eNO], carbon monoxide [eCO], and high-resolution computed tomography [HRCT] of the lungs) from prospective 3.5-year observational study cohort nine daily EC users (mean age 29.7 (±6.1)...

10.1038/s41598-017-14043-2 article EN cc-by Scientific Reports 2017-10-17

Electronic cigarettes (e-cigs) are marketed as safer alternatives to tobacco and have shown reduce their consumption. Here we report for the first time effects of e-cigs on subjective objective asthma parameters well tolerability in asthmatic smokers who quit or reduced consumption by switching these products. We retrospectively reviewed changes spirometry data, airway hyper-responsiveness (AHR), exacerbations control smoking asthmatics switched regular e-cig use. Measurements were taken...

10.3390/ijerph110504965 article EN International Journal of Environmental Research and Public Health 2014-05-08

We present prospective blood pressure (BP) and hear rate (HR) changes in smokers invited to switch e-cigarettes the ECLAT study. BP HR were compared among (1) different study groups (users of high, low, zero nicotine products) (2) pooled continuous smoking phenotype classification (same from week 12 -52), with participants classified as quitters (completely quit smoking), reducers (≥50 % reduction consumption) failures (<50 or no consumption). Additionally, latter comparison was repeated a...

10.1007/s11739-015-1361-y article EN cc-by Internal and Emergency Medicine 2016-01-09

Electronic cigarettes (ECs) are battery-operated devices designed to vaporise nicotine, which may help smokers quitting or reducing their tobacco consumption. There is a lack of data on the health effects EC use among with COPD and whether regular results in improvement subjective objective outcomes. We investigated long-term changes respiratory outcomes diagnosis who quit reduced substantially consumption by supplementing converting only ECs use. conducted retrospective chart review...

10.1186/s12931-016-0481-x article EN cc-by Respiratory Research 2016-12-01

Quitting smoking is the most important step smokers can take to improve their health. Nonetheless, there little information on long-term improvements in lung function and/or respiratory symptoms after cessation. Here we illustrate changes spirometric indices as well invited quit or reduce cigarette consumption by switching electronic cigarettes (ECs). Prospective evaluation of consumption, spirometry and was performed a 1-year randomized controlled trial receiving EC containing 2.4%, 1.8% 0%...

10.1042/cs20160268 article EN Clinical Science 2016-08-20

Given that many patients with chronic obstructive pulmonary disease (COPD) smoke despite their symptoms, it is important to understand the long-term health impact of cigarette substitution heated tobacco products (HTPs). We monitored parameters for 3 years in COPD who substantially attenuated or ceased consumption after switching HTPs. Changes daily smoking, annualized exacerbations, lung function indices, patient-reported outcomes (CAT scores) and 6-minute walk distance (6MWD) from baseline...

10.1007/s11739-021-02674-3 article EN cc-by Internal and Emergency Medicine 2021-03-23

People who smoke and face challenges trying to quit or wish continue may benefit by switching from traditional cigarettes noncombustible nicotine delivery alternatives, such as heated tobacco products (HTPs) electronic (ECs). HTPs ECs are being increasingly used smoking, but there limited data about their effectiveness.

10.2196/42628 article EN cc-by JMIR Public Health and Surveillance 2023-02-05

Background Problematic TikTok Use (PTU) is a psychological condition marked by compulsive and excessive engagement with the app, often characterized prolonged scrolling, content interaction, seeking user feedback. Methods This qualitative study, conducted from February to March 2024, explored factors driving addiction, its consequences, strategies for mitigation. Data were collected through in-depth interviews surveys 56 participants (23 men, 33 women). Results Thematic analysis identified...

10.52965/001c.127796 article EN cc-by-nc Health psychology research 2025-01-06

Little is known about the association between cigarette smoking and asthma severity. We assessed as a determinant of disease severity control in cohort clinic-referred allergic subjects who developed new onset asthma. Allergic rhinitis with no (n = 371) were followed-up for 10 years routinely examined diagnosis. In those 152), clinical levels determined. Among these subjects, 74 (48.7%) current smokers, 17 (11.2%) former 61 (40.1%) never smokers. When comparing or past smokers to they had...

10.1186/1465-9921-12-16 article EN cc-by Respiratory Research 2011-01-25

Health effects of electronic cigarette (EC) use in patients with chronic obstructive pulmonary disease (COPD) are largely unexplored.We present findings from a long-term prospective assessment respiratory parameters cohort COPD who ceased or substantially reduced conventional ECs.We prospectively re-evaluated exacerbations, spirometric indices, subjective assessments (using the Assessment Tool [CAT] scores), physical activity (measured by 6-minute walk distance [6MWD]), and EC users were...

10.2147/copd.s161138 article EN cc-by-nc International Journal of COPD 2018-08-01

Abstract Background Electronic cigarette ( EC ) use is an emerging behaviour that has been shown to help smokers reduce consumption. The aim of this study was illustrate long‐term changes in exhaled breath measurements and respiratory symptoms invited quit or their consumption by switching s. Materials methods Prospective evaluation consumption, fractional nitric oxide concentration (Fe NO ), carbon monoxide eCO symptom scores performed a 1‐year randomized, controlled trial ‘healthy’...

10.1111/eci.12651 article EN European Journal of Clinical Investigation 2016-06-20

Background and Aims: The long-term health effects of the use electronic cigarettes (ECs) in patients with chronic obstructive pulmonary disease (COPD) are largely unexplored. We present findings from a 5-year prospective assessment respiratory parameters cohort COPD who substantially reduced conventional smoking or achieved abstinence by switching to ECs. Methods: Patients were evaluated prospectively for their measurements exacerbations, spirometric indices, quality life using tool (CAT),...

10.1177/2040622320961617 article EN cc-by-nc Therapeutic Advances in Chronic Disease 2020-01-01

Electronic cigarettes (ECs) are battery-operated devices designed to vaporise nicotine, which may help smokers with quitting or reducing their tobacco consumption. No data is available regarding the health effects of ECs use among arterial hypertension and whether regular results in blood pressure (BP) changes. We investigated long-term changes resting BP level control hypertensive who quit reduced substantially consumption by switching ECs. A medical records review patients was conducted...

10.3390/ijerph13111123 article EN International Journal of Environmental Research and Public Health 2016-11-11

Vaping cessation is virtually unexplored. The efficacy and safety of varenicline for vaping has not been studied rigorous research required to advance best practice outcomes people who use electronic cigarettes (EC) want quit. objective evaluate the (1 mg BID, administered 12 weeks, with follow-up week 24) combined counseling in exclusive daily EC users intending quit vaping. Design: Double-blind, randomized, parallel-group, placebo-controlled trial. study took place at a University-run...

10.1186/s12916-023-02919-2 article EN cc-by BMC Medicine 2023-07-05
Coming Soon ...